These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10439195)
41. Increased liver and spleen accumulation of Tc-99m methylene diphosphonate associated with intravenous injection of MRI contrast gadolinium-diethylenetriaminepentaacetic acid. Zhang W; Zhang Y; Li X; Jin Z Clin Nucl Med; 2011 Mar; 36(3):183-5. PubMed ID: 21285674 [TBL] [Abstract][Full Text] [Related]
42. Demonstration of the ascending colon on Tc-99m MDP skeletal imaging: pitfall in bone scanning by a faith cure of drinking urine. Kosuda S; Katagiri S; Ka WJ; Tominaga S; Kusano S Clin Nucl Med; 2000 Dec; 25(12):1040-1. PubMed ID: 11129147 [No Abstract] [Full Text] [Related]
43. Bone scintigraphy with 99mTc-MDP formulated by a novel, simple and rapid sonication method: clinical results. Goomer NC; Duggal RK; Prakash R Eur J Nucl Med; 1999 Dec; 26(12):1633-4. PubMed ID: 10638421 [No Abstract] [Full Text] [Related]
44. Parathyroid adenoma localization with 99mTc-MDP bone scintigraphy. Bohmer DR; Mercer MP; Turner GJ Aust N Z J Surg; 2000 Nov; 70(11):817-9. PubMed ID: 11147446 [No Abstract] [Full Text] [Related]
45. Lutein cyst inadvertently detected on Tc-99m MDP whole-body bone scintigraphy. Kida T; Takahashi S Clin Nucl Med; 1998 Jan; 23(1):52-3. PubMed ID: 9442974 [No Abstract] [Full Text] [Related]
46. Intracranial Tc99m MDP uptake in Sturge-Weber syndrome. Hui C; Lau KK Australas Radiol; 2003 Mar; 47(1):75-7. PubMed ID: 12581062 [TBL] [Abstract][Full Text] [Related]
47. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions. Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350 [TBL] [Abstract][Full Text] [Related]
48. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication. Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136 [TBL] [Abstract][Full Text] [Related]
49. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. Worsley DF; Lentle BC J Nucl Med; 1993 Sep; 34(9):1612-5. PubMed ID: 8355083 [No Abstract] [Full Text] [Related]
50. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia. Castaigne C; Martin P; Blocklet D Clin Nucl Med; 2003 Jun; 28(6):467-71. PubMed ID: 12911094 [TBL] [Abstract][Full Text] [Related]
53. Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions. De Marini P; Laplace A; Matuszak J; Fornecker LM; Namer IJ Clin Nucl Med; 2016 Oct; 41(10):802-3. PubMed ID: 27454596 [TBL] [Abstract][Full Text] [Related]
54. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Wulfrank DA; Schelstraete KH; Small F; Fallais CJ Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315 [TBL] [Abstract][Full Text] [Related]
55. Discrepancy between clinical symptoms and Tc-99m MDP bone scan findings before and after strontium-89 therapy for metastatic bone pain of prostate carcinoma. Sun SS; Tsai SC; Hsieh JF; Lee JK; Kao CH Clin Nucl Med; 2001 Feb; 26(2):167-9. PubMed ID: 11201488 [No Abstract] [Full Text] [Related]